Spot Trading’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$2.47M Buy
26,400
+11,100
+73% +$1.18M 0.04% 614
2017
Q2
$1.7M Buy
+15,300
New +$1.62M 0.03% 745
2017
Q1
Sell
-2,100
Closed -$193K 2996
2016
Q4
$193K Sell
2,100
-200
-9% -$17.2K ﹤0.01% 1943
2016
Q3
$195K Buy
+2,300
New +$193K ﹤0.01% 2105
2016
Q1
Sell
-17,900
Closed -$1.27M 3528
2015
Q4
$1.27M Buy
17,900
+5,400
+43% +$363K 0.01% 1293
2015
Q3
$768K Buy
+12,500
New +$874K 0.01% 1774
2015
Q1
Sell
-300
Closed -$20K 3973
2014
Q4
$20K Sell
300
-4,200
-93% -$265K ﹤0.01% 3584
2014
Q3
$273K Sell
4,500
-6,900
-61% -$425K ﹤0.01% 2965
2014
Q2
$669K Sell
11,400
-7,400
-39% -$433K ﹤0.01% 2454
2014
Q1
$1.09M Sell
18,800
-7,000
-27% -$375K 0.01% 1972
2013
Q4
$1.38M Buy
25,800
+10,300
+66% +$611K 0.01% 1759
2013
Q3
$958K Buy
15,500
+1,400
+10% +$83.8K 0.01% 1942
2013
Q2
$855K Buy
+14,100
New +$840K 0.01% 2045

Other funds holding DGX

Spot Trading's DGX Position: Q1 2017 in Review

Spot Trading sold out of Quest Diagnostics (DGX) in Q1 2017, closing a stake of 229 shares — an estimated $21K sold.

Spot Trading first reported a position in DGX in Q2 2014 and held it in 9 quarters. The position peaked at $1M in Q4 2014. 614 funds tracked by Wall St. Rank hold DGX as of Q1 2017.

  • Spot Trading reported no remaining Quest Diagnostics position as of Q1 2017 after selling out during the quarter.
  • Spot Trading sold 229 Quest Diagnostics shares in Q1 2017, an estimated $21K.
  • Spot Trading first reported a position in Quest Diagnostics in Q2 2014 and held it in 9 quarters.
  • Spot Trading's Quest Diagnostics position peaked at $1M in Q4 2014.
  • 614 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2017.

Based on Spot Trading's 13F filing for Q1 2017, filed 1 May 2017.